公开(公告)号：EP1386606A4

公开(公告)日：2007-12-12

申请号：EP02724736

申请日：2002-05-09

申请人： MITSUBISHI PHARMA CORP

发明人： YOSHIDA HIROSHI ,  MATSUO NAOKI ,  CHIBA MASATOSHI

IPC分类号： A61K31/4152 ,  A61K9/08 ,  A61K47/10 ,  A61K47/18 ,  A61P9/00 ,  A61P9/10 ,  C07D231/20

CPC分类号： C07D231/20 ,  A61K9/0019 ,  A61K31/4152 ,  A61K47/10 ,  A61K47/186

摘要： An injection which contains as the active ingredient a pyrazolone derivative which typically is edaravon, a physiologically acceptable salt thereof, or a hydrate or solvate of either in an amount of 3 to 60 mg/mL. It is excellent in long-term stability, product storage, and suitability for use.